CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,007	2,936	2,895	5,519	9,630	11,596
Market Cap Growth	298.60%	1.42%	-47.55%	-42.69%	-16.96%	11.17%
Enterprise Value	12,680	2,374	2,021	4,205	6,648	9,164
Last Close Price	8.88	2.30	2.27	4.63	8.27	10.08
PS Ratio	58.62	6.78	5.67	10.14	32.19	9.40
PB Ratio	37.68	7.58	5.75	10.87	6.50	3.31
P/TBV Ratio	74.41	13.62	9.26	16.86	6.90	3.31
EV/Sales Ratio	57.15	5.48	3.95	7.73	22.22	7.43
Debt / Equity Ratio	1.24	0.98	0.80	0.64	0.14	0.03
Asset Turnover	0.15	0.27	0.28	0.25	0.08	0.31
Inventory Turnover	1.38	0.85	2.44	4.86	-	-
Quick Ratio	1.20	1.18	1.44	1.29	2.03	4.91
Current Ratio	1.44	1.60	1.56	1.32	2.10	4.91
Return on Equity (ROE)	-96.36%	-22.23%	-81.05%	-109.00%	-92.28%	-44.92%
Return on Assets (ROA)	-16.92%	-3.90%	-21.93%	-29.16%	-37.90%	-20.33%
Return on Capital (ROIC)	-30.55%	-7.74%	-46.53%	-53.86%	-51.74%	-24.71%
Earnings Yield	-3.18%	-3.31%	-13.98%	-18.49%	-24.47%	-12.50%
FCF Yield	-	-12.44%	-22.41%	-12.51%	-20.08%	-5.89%
Buyback Yield / Dilution	-1.04%	-1.04%	-7.69%	-0.66%	-11.39%	-20.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.